Stock RESPIRERX PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Strategies Respirerx Pharmaceuticals Inc Other OTC

Equities

US2205243007

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for Respirerx Pharmaceuticals Inc
Apr. 10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
Mar. 20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. Stock
  5. News Respirerx Pharmaceuticals Inc
  6. MarketScreener Strategies